Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01395381

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Benefit of Antihelminthic Therapy in the Community-Based Treatment of Severe Acute Malnutrition in Malawian Children

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
6 Months – 59 Months
Healthy volunteers
Not accepted

Summary

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboplacebo given once
DRUGAlbendazolesingle dose albendazole given at the time of enrollment

Timeline

Start date
2013-01-01
Primary completion
2014-01-01
First posted
2011-07-15
Last updated
2014-01-28

Locations

1 site across 1 country: Malawi

Source: ClinicalTrials.gov record NCT01395381. Inclusion in this directory is not an endorsement.

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition (NCT01395381) · Clinical Trials Directory